Home | About | Donate

'Absolute Robbery': Gilead Announces $3,120 Price Tag for Covid-19 Drug Developed With $70 Million in Taxpayer Support

They are Western style doctors in a medical group.

I found this executive presidential directive on PPP and vaccines too. It is a bit odd forming this type of task force.


What is PPP? Do you really mean “PPE” (personal protective equipment, i.e. protective clothing masks, gloves, face shields, respirators, etc. for use in preventing health workers from getting contagious disease. )

Didnt we have one until recently and Trump disbanded it?

I will answer both posts here: PPP are Public-Private Partnerships with origins in Title 3 of the federal code. Applied in the World Health Organization in regard to health services, and amended by the executive directive by Pres. Trump in 2019 that established a PPP task force on vaccines that is quite extensive.

The history of how Gilead is able to announce it’s price tag for drug development and sales.

“Sec. 3. National Influenza Vaccine Task Force. (a) There is hereby established a National Influenza Vaccine Task Force (Task Force). The Task Force shall identify actions to achieve the objectives identified in section 2 of this order and monitor and report on the implementation and results of those actions. The Task Force shall be co-chaired by the Secretary of Defense and the Secretary of Health and Human Services, or their designees.
(b) In addition to the Co-Chairs, the Task Force shall consist of a senior official from the following executive branch departments, agencies, and offices:
(i) the Department of Defense (DOD);
(ii) the Department of Justice;
(iii) the Department of Agriculture;
(iv) the Department of Veterans Affairs (VA);
(v) the Department of Homeland Security;
(vi) the United States Food and Drug Administration;
(vii) the Centers for Disease Control and Prevention;
(viii) the National Institutes of Health (NIH);
(ix) the Centers for Medicare and Medicaid Services (CMS); and
(x) the Biomedical Advanced Research and Development Authority (BARDA).”

It is a little confusing because Title 3 covers a lot of partnerships from education to other business.

Neoliberal ideology doesn’t allow governments to compete with industry. Thats why PPPs are the only means available under this ideology. Also, Neoliberal ideology is against any kind of price controls, basically its a cult that believes that only the “invisible hand” of the market should decide prices.

It needs to be said here that cults are very dangerous things and that a lot of signs exist that we’re being run by a warlike and apocalyptic cult pretending to be two parties. Its a doomsday cult in the sense that it wants to bring the society we live in now crashing down - its not a normal government. Many people can sense that but they have no idea how badlty we are being lied to.

As far as this drug issue, we should be aware that other countries in the world are rejecting the ideology we’re pushing now, when it comes to COVID-19. The president of Costa Rica proposed a COVID-19 technology pool and it represnts a new model for sharing information. The WHO put forward and announced the establishment of this technology pool and we quit the WHO it seems in protest.

1 Like

I would agree. It is confusing on purpose too. I watched a Ted Talk by an International Health professional which touched on this subject and makes sense, an International response entity for surveillance of infectious disease. I think the U.S. is determined to exploit this as much as possible.

Its not just the US, several EU countries have a lot of Big Pharma too. I think Gilead is a French country that is also in the US. An NGO “KEI”, (keionline dot org) has a lively listserv (mailing list) called ip-health which has a lot of info on the various issues.

U.S. Big Pharma has a presence all over the world, in India and China respectively. Medicare can’t negotiate drug prices because big pharma is already doing that. Thank you for the info. I bookmarked it for another time.

The product is not effective enough for people to be certain it works, at all.

Wonder how much corporations will want for something that clearly DOES WORK?

Should Congress respond by placing a company income tax of at least 90% on COVID-19 treatments developed with taxpayer support? Perhaps only on the fraction of the price that was the same as the fraction of the development costs payed by taxpayers?

Look up TRIPS Agreement, shortly after it came into force the NIH abolished the Reasonable Pricing Rule. We wrote international legislation that makes rules like that illegal unless you are one of the poorest countries.

Also see the Doha Declaration on the TRIPS agreement and Public Health. Something the US opposes to its very soul. Its against everything we (now) stand for for medicines to be affordable for all.


WHAT??? I knew the USA, like many other countries, is, in national (and state) terms, terminally insane - but this…?


Read this! Its a must-read.
If only we could take advantage of this! But we are totally against it.
Essential medicines and health products



In 2001, WTO Members adopted a special Ministerial Declaration at the WTO Ministerial Conference in Doha to clarify ambiguities between the need for governments to apply the principles of public health and the terms of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). In particular, concerns had been growing that patent rules might restrict access to affordable medicines for populations in developing countries in their efforts to control diseases of public health importance, including HIV, tuberculosis and malaria. The Declaration responds to the concerns of developing countries about the obstacles they faced when seeking to implement measures to promote access to affordable medicines in the interest of public health in general, without limitation to certain diseases. While acknowledging the role of intellectual property protection “for the development of new medicines”, the Declaration specifically recognizes concerns about its effects on prices.

The Doha Declaration affirms that “the TRIPS Agreement does not and should not prevent Members from taking measures to protect public health”. In this regard, the Doha Declaration enshrines the principles WHO has publicly advocated and advanced over the years, namely the re-affirmation of the right of WTO Members to make full use of the safeguard provisions of the TRIPS Agreement in order to protect public health and enhance access to medicines for poor countries.

The Doha Declaration refers to several aspects of TRIPS, including the right to grant compulsory licenses and the freedom to determine the grounds upon which licences are granted, the right to determine what constitutes a national emergency and circumstances of extreme urgency, and the freedom to establish the regime of exhaustion of intellectual property rights.

Compulsory Licences

The TRIPS Agreement allows the use of compulsory licences. Compulsory licensing enables a competent government authority to license the use of a patented invention to a third party or government agency without the consent of the patent-holder. Article 31 of the Agreement sets forth a number of conditions for the granting of compulsory licences. These include a case-by-case determination of compulsory licence applications, the need to demonstrate prior (unsuccessful) negotiations with the patent owner for a voluntary licence and the payment of adequate remuneration to the patent holder. Where compulsory licences are granted to address a national emergency or other circumstances of extreme urgency, certain requirements are waived in order to hasten the process, such as that for the need to have had prior negotiations obtain a voluntary licence from the patent holder. Although the Agreement refers to some of the possible grounds (such as emergency and anticompetitive practices) for issuing compulsory licences, it leaves Members full freedom to stipulate other grounds, such as those related to non-working of patents, public health or public interest. The Doha Declaration states that each Member has the right to grant compulsory licences and the freedom to determine the grounds upon which such licences are granted.

Parallel Importation

Parallel importation is importation without the consent of the patent-holder of a patented product marketed in another country either by the patent holder or with the patent-holder’s consent. The principle of exhaustion states that once patent holders, or any party authorized by him, have sold a patented product, they cannot prohibit the subsequent resale of that product since their rights in respect of that market have been exhausted by the act of selling the product. Article 6 of the TRIPS Agreement explicitly states that practices relating to parallel importation cannot be challenged under the WTO dispute settlement system. The Doha Declaration has reaffirmed that Members do have this right, stating that each Member is free to establish its own regime for such exhaustion without challenge.

Since many patented products are sold at different prices in different markets, the rationale for parallel importation is to enable the import of lower priced patented products. Parallel importing can be an important tool enabling access to affordable medicines because there are substantial price differences between the same pharmaceutical product sold in different markets.

Extension of transition period for Least-Developed Countries (LDCs)

The Doha Declaration also extended the transition period for LDCs for implementation of the TRIPS obligations from 2006 to 2016. However, the extension is limited to the obligations under provisions in the TRIPS Agreement relating to patents and marketing rights, and data protection for pharmaceutical products. Thus, LDCs are still obliged to implement the rest of their obligations under the TRIPS Agreement as of 2006. From a public health perspective, this extension of the transition period for LDCs is of significant importance. It is a recognition of the implications of patent protection on public health, and thus, it is recommended that all LDCs adopt the necessary measures to use the 2016 transition period in relation to pharmaceutical patents and test data protection.

Related publications:

Remuneration guidelines for non-voluntary use of a patent on medical technologies
WHO/TCM/2005.1 pdf, 650kb

Implications of the Doha Declaration on the TRIPS agreement and public health
WHO/EDM/PAR/2002.3 pdf, 159kb

Doha Declaration on the TRIPS Agreement and Public Health
WT/MIN(01)/DEC/W/2, 14 November 2001 pdf, 10kb

1 Like

It’s the American plutocratic game; use Public Money to Create Private Profit. Go along with this scheme and a few crumbs will fall off the table as crumbs to the masses. If you don’t… then who knows what will happen! Fear of the unknown keeps the masses in line.

1 Like

No crumbs fall off this table.

Only to the poorest countries.

Here, no way, there is a entitlement to make high yields some people feel they have. They are insiders and they feel they have a right to make huge profits. They rigged our political system to keep it that way.

So the question is what do we do about it. Voting is a pure waste of time and effort. The very few people running that might be worth our vote either will not win, or they will make it to elected office and be rendered impotent or they will be persuaded to join the crowd of the plutocratically owned vast majority of career politicians and reap the financial and position benefits of selling out. We are doomed to more of the same until that time people rise up and say enough and truly mean it.

Stop letting them lie in the press. Stop letting them pretend things are normal. When the media starts parroting lies, tell them, “No, they lied”. I hate to say it but Bernie and Pramilla Jayapal also have lied by pretending GATS isnt there. We have to make it clear we cannot be lied to to protect the guilty.

Let me remind people that the House Progressives were extremely cold to the late Nick Skala, - who wrote the best paper on the issue.


Its not enough to say all the right things for 1992 in 2020. After a million poor people have died.

In 2020 its entirely the wrong thing. We need to be telling people we’re going to figure a way to get out of GATS. Refuse to vote for Biden or Trump. GATS is a theft of the future. The people who buy into this scheme are stealing our country.

Take it to the world’s people. We should get out of TRIPS too. No more deal making with crooks. Once we do that we’ll start winning.

Thanks for supplying this information.

All they need to do is include this fact in the information they provide us. We need to leave GATS via the provided Article XXI to avoid any hint of a potential loss of Medicare and Social Security triggered by expanding Medicare beyond the retired - which is explicitly laid out in the GATS Annex on Financial Services as what happens if we expand it beyond people who are covered by Social Security (the powers that be really want to get rid of Social Security, because they plan on outsourcing millions of jobs which will cut a lot of peoples working lives short. And Social Security is standing in the way of outsourcing jobs.

Why? Our workers labor is more expensive and they would rather use cheaper labor in high skill professions, its also been framed as helping the Third World catch up with the US and EU in total number of billionaires and millionaires. (NO IT WONT HELP THE POOR, IT WILL HELP THE RICH PEOPLE KEEPING POOR COUNTRIES POOR).

Promise to eliminate our obligations under GATS and not trigger the trap.

And not pretend GATS doesn’t exist.